# Oncologic Therapy Support Via Means of a Dedicated Mobile App

> **NCT03168048** · NA · UNKNOWN · sponsor: **Heidelberg University** · enrollment: 50 (estimated)

## Conditions studied

- Thoracic Neoplasm
- Pelvic Neoplasm
- Radiotherapy; Complications
- Oncologic Disorders
- Breast Cancer
- Satisfaction
- Quality of Life

## Interventions

- **OTHER:** mobile application

## Key facts

- **NCT ID:** NCT03168048
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2017-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03168048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03168048, "Oncologic Therapy Support Via Means of a Dedicated Mobile App". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03168048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*